Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuroepidemiology

• Publication date

  2016-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000450855PMID 28135712PMCID PMC5465963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lifestyle, family history, and risk of idiopathic Parkinson disease: a large Danish case-control study.

  2015cited by this paper
• Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson Disease

  2014cited by this paper
• Dose–response meta‐analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease

  2014cited by this paper
• A genome-wide association study of caffeine-related sleep disturbance: confirmation of a role for a common variant in the adenosine receptor.

  2012cited by this paper
• Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s disease

  2011cited by this paper
• An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson’s disease

  2011cited by this paper
• Caffeine and Parkinson’s disease: are we getting our fix on risk‐modifying gene‐environment interactions?

  2011cited by this paper
• Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease.

  2010cited by this paper
• Prospective study of coffee consumption and risk of Parkinson's disease

  2008cited by this paper
• Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.

  2008cited by this paper
• An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors.

  2008cited by this paper
• Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study

  2008cited by this paper
• Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine

  2007cited by this paper
• Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease

  2006cited by this paper
• KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse.

  2005cited by this paper
• Association Between A2a Receptor Gene Polymorphisms and Caffeine-Induced Anxiety

  2003cited by this paper
• A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

  2002cited by this paper
• Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease

  2001cited by this paper
• Evidence for Adenosine/Dopamine Receptor Interactions: Indications for Heteromerization

  2000cited by this paper
• Association of coffee and caffeine intake with the risk of Parkinson disease.

  2000cited by this paper
• Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.

  1999cited by this paper
• Diet and Parkinson's disease I

  1996cited by this paper
• A retrospective study of smoking in Parkinson's disease.

  1968cited by this paper
• Edinburgh Research Explorer Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee

  year unknowncited by this paper

• Two novel iron metabolism-related genes identified as diagnostic indicators in substantia nigra of patients with Parkinson's disease.

  2026cites this paper
• Dual-Risk axis: GBA1 mutations and occupational pesticide exposure in Parkinson's disease.

  2026cites this paper
• Long-term outcomes associated with istradefylline versus catechol-O-methyltransferase inhibitors in patients with Parkinson's disease: a nationwide real-world cohort study.

  2026cites this paper
• PARKINSON’S DISEASE AND OCCUPATIONAL EXPOSURE: A CASE-CONTROL STUDY CONDUCTED IN SOUSSE (TUNISIA)

  2025cites this paper
• The role of cytochrome P450 and gut microbiome in drug metabolism: Insights into Parkinson disease treatment.

  2025cites this paper
• Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review

  2024cites this paper
• Microbiome-based therapeutics for Parkinson's disease

  2024cites this paper
• The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease

  2024cites this paper
• Interaction between Caffeine Consumption & Genetic susceptibility in Parkinson's disease: a systematic review.

  2024cites this paper
• Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure

  2024cites this paper
• Genic-intergenic polymorphisms of CYP1A genes and their clinical impact.

  2023cites this paper
• Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease

  2023cites this paper
• The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease

  2023cites this paper
• Adenosinergic Pathway in Parkinson’s Disease: Recent Advances and Therapeutic Perspective

  2023cites this paper
• Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease

  2022cites this paper
• QUALIDADE

  2022cites this paper
• Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.

  2022cites this paper
• Analysis of ADORA2A rs5760423 and CYP1A2 rs762551 Genetic Variants in Patients with Alzheimer’s Disease

  2022cites this paper
• Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease

  2022cites this paper
• Relationship between Nutrition, Lifestyle, and Neurodegenerative Disease: Lessons from ADH1B, CYP1A2 and MTHFR

  2022cites this paper
• Roles of clock genes in the pathogenesis of Parkinson's disease.

  2021cites this paper
• Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases

  2021cites this paper
• ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease

  2021cites this paper
• Bad News, Good News – The demographics and genetic and environmental risk factors for Parkinson's disease

  2021cites this paper
• Coffee: All You Need to Know

  2021cites this paper
• C-caffeine breath test results show high dependence of aryl-hydrocarbon receptor SNPs Author Names

  2020cites this paper
• Narrative Review: Impact of Genetic Variability of CYP1A2, ADORA2A, and AHR on Caffeine Consumption and Response

  2020cites this paper
• Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson’s disease?

  2020cites this paper
• Caffeine Compromises Proliferation of Human Hippocampal Progenitor Cells

  2020cites this paper
• CYP1A2 rs762551 polymorphism and risk for amyotrophic lateral sclerosis

  2020cites this paper
• The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis

  2020cites this paper
• CYP1A2 rs762551 and ADORA2A rs5760423 Polymorphisms in Patients with Blepharospasm

  2020cites this paper
• Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

  2020cites this paper
• 13C-caffeine breath test identifies single nucleotide polymorphisms associated with caffeine metabolism.

  2020cites this paper
• Parkinson’s Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East

  2020cites this paper
• Manganese activates NLRP3 inflammasome signaling and propagates exosomal release of ASC in microglial cells

  2019cites this paper
• Coffee Consumption and Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis of Prospective Studies

  2019cites this paper
• Parkinson's Disease and the Environment

  2019cites this paper
• Inertial-sensor based 3D kinematics in the differential diagnosis between Parkinson's disease and atypical parkinsonism

  2019cites this paper
• Biases Inherent in Studies of Coffee Consumption in Early Pregnancy and the Risks of Subsequent Events

  2018cites this paper
• Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk

  2018cites this paper
• Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption

  2018cites this paper
• Interactions Between Genetics, Lifestyle, and Environmental Factors for Healthcare.

  2017cites this paper
• Exploring the Association between Statin Use and the Risk of Parkinson’s Disease: A Meta-Analysis of Observational Studies

  2017cites this paper